S. P. Borriello, W. Topley, G. S. Wilson, É. Clostridium, and C. Tetani, Topley & Wilson's microbiology & microbial infections, vol.2, pp.1035-88, 2005.

L. M. Prescott, La classe des Clostridia. In: Microbiologie. Bruxelles

D. H. Smith, G. L. Timms, and M. Refai, Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as « Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus, Zeitschrift für Hygiene und Infektionskrankheiten, vol.73, issue.2, pp.701-720, 1897.

L. D. Smith and H. Sugiyama, Botulism: the organism, its toxins, the disease

I. Springfield, USA: Thomas, 1988.

B. C. Jansen and P. C. Knoetze, The taxonomic position of Clostridium botulinum type

, Onderstepoort J Vet Res. juin, vol.44, issue.2, pp.53-57, 1977.

J. B. Gunnison, J. R. Cummings, and K. F. Meyer,

, Soc Exp Biol Med, vol.35, issue.2, pp.278-80, 1936.

V. Moller and I. Scheibel, Preliminary report on the isolation of an apparently new type of CI. botulinum, Acta Pathol Microbiol Scand, vol.48, p.99, 1960.

J. R. Barash, S. S. Arnon, E. Pilly, O. Épaulard, L. Berre et al., A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins, Collège des universitaires de maladies infectieuses et tropicales (France). Botulisme. In: Maladies infectieuses et tropicales. la santé publique -Article, vol.209, pp.183-91, 2014.

, Code de la santé publique -Article D3113-6. Code de la santé publique

, Caractéristiques épidémiologiques du botulisme humain en 2016

D. Sur,

F. Bricaire, P. Bossi, and . Botulisme, , pp.46-55, 2003.

B. Poulain, E. Lonchamp, E. Jover, M. R. Popoff, and J. Molgó,

, Ann Dermatol Venereol. mai, vol.136, pp.73-76, 2009.

G. Amarenco and A. Durand, Toxines botuliques : mode d action

Y. Humeau, F. Doussau, N. J. Grant, and B. Poulain, How botulinum and tetanus neurotoxins block neurotransmitter release, Biochimie. mai, vol.82, issue.5, pp.427-473, 2000.

S. S. Arnon, R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett et al., Botulinum toxin as a biological weapon: medical and public health management, JAMA. 28 févr, vol.285, issue.8, 2001.

S. S. Arnon, R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett et al., Botulinum Toxin as a Biological Weapon

, JAMA. 28 févr, vol.285, issue.8, pp.1059-70, 2001.

. Lepretre-s, La toxine botulique en médecine physique et réadaptation, 2006.

D. Truong, Manual of botulinum toxin therapy

A. B. Scott, Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery, Ophthalmology. oct, vol.87, issue.10, pp.1044-1053, 1980.

J. K. Tsui, A. Eisen, E. Mak, J. Carruthers, A. Scott et al., Bonventre PF, Kempe LL. Physiology of toxin production by Clostridium botulinum types A and B. IV. Activation of the toxin, 26. Frevert J. Xeomin is free from complexing proteins. Toxicon Off J Int Soc Toxinology, vol.12, issue.4, pp.697-701, 1960.

F. Scaglione, Conversion Ratio between Botox®, Dysport®, and Xeomin® in

C. Chu-grenoble-alpes--réseau and . Chu,

D. Sur,

. Sar-a-s, Réflexion sur la manière de sécuriser le circuit de la toxine botulique au CHU de Grenoble

D. Sur,

D. Sur,

D. Sur, Plan de gestion de risque des spécialités pharmaceutiques à base de toxine botulinique A ou B

D. Sur,

, PHP: Hypertext Preprocessor, Usage Statistics and Market Share of Server-side Programming Languages

. Websites, , 2018.

D. Sur, , p.28

D. Sur,

D. Sur,